Company: ACBM
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001640334-25-001281
Chunk: 3

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 3
---
ensation   Deficit   Equity (Deficit)                          Balance, December 31, 2022  -  $-   60,042,000  $60,042  $32,295,236  $(8,060,983) $(23,807,925) $486,370                                  Amortization of deferred stock compensation   -   -   -   -   -   3,928,100   -   3,928,100 Imputed interest on related party loans  -   -   -   -   788   -   -   788 Net loss  -   -   -   -   -   -   (4,004,354)  (4,004,354)                                 Balance, March 31, 2023  -   -   60,042,000   60,042   32,296,024   (4,132,883)  (27,812,279)  410,904                                  Amortization of deferred stock compensation   -   -   -   -   -   3,123,450   -   3,123,450 Imputed interest on related party loans  -   -   -   -   789   -   -   789 Net loss  -   -   -   -   -   -   (3,195,489)  (3,195,489)                                 Balance, June 30, 2023  -   -   60,042,000   60,042   32,296,813   (1,009,433)  (31,007,768)  339,654                                  Amortization of deferred stock compensation   -   -   -   -   -   1,009,433   -   1,009,433 Imputed interest on related party loans  -   -   -   -   790   -   -   790